Phase II Study Suggests Future For Radioembolisation In Patients With Advanced Hepatocellular Carcinoma (HCC)
Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC ± portal vein thrombosis, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. According to the researchers, these findings create the foundation for a trial comparing and combining radioembolisation with multi-targeted kinase inhibitor, sorafenib.
Subscribe to:
Posts (Atom)
